News

Tiziana Life Sci PLC - License Agreement

RNS Number: 9522 K Tiziana Life Sciences PLC 16 April 2018 Tiziana Life Sciences plc. Tiziana Life Sciences announces an exclusive license agreement for novel technology relating to nasal administration of Foralumab for the treatment of neurodegenerative diseases. London, 16 April 2018- Tiziana Life Sciences plc, a clinical stage biotechnology company...

RNS Number: 9522 K Tiziana Life Sciences PLC 16 April 2018 Tiziana Life Sciences plc. Tiziana Life Sciences announces an exclusive license agreement for novel technology relating to nasal administration of Foralumab for the treatment of neurodegenerative diseases. London, 16 April 2018- Tiziana Life Sciences plc, a clinical stage biotechnology company...

Share